Key result
Drug-coated balloon angioplasty combined with single anti-platelet therapy was successfully used to treat acute coronary syndrome in a patient with a recent haemorrhagic stroke.
Case Report (n=1)
Drug-coated balloon angioplasty combined with single anti-platelet therapy may be a feasible and safe revascularization strategy for patients presenting with acute coronary syndrome and an extremely high bleeding risk.
Single-case success with drug-coated balloon plus single antiplatelet therapy in ACS after hemorrhagic stroke; leaves open need for prospective validation.
A 55-year-old male presented with two challenging problems, i.e. acute coronary syndrome (ACS) and a major bleeding episode. He first presented with ischaemic stroke and was treated with thrombolysis. However this was complicated by haemorrhagic transformation. He subsequently developed ACS with urgent coronary angiography demonstrating a critical stenosis in the proximal left anterior descending artery. Percutaneous coronary intervention (PCI) was deemed necessary but we were mindful of causing bleeding complications from the use of anti-thrombotic therapy. Despite the complexities, we used a novel approach in terms of PCI strategy and anti-platelet regimen (drug-coated balloon angioplasty and a single anti-platelet therapy) and achieved a successful outcome.
No takes yet. Share an insight, caveat, or question.
Ho et al. (2016) conducted a case report in Acute coronary syndrome and major bleeding episode (n=1). Drug-coated balloon angioplasty and single anti-platelet therapy was evaluated on Successful outcome. Drug-coated balloon angioplasty combined with single anti-platelet therapy was successfully used to treat acute coronary syndrome in a patient with a recent haemorrhagic stroke.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: